Zhejiang Medicine Co., Ltd. (SHA:600216)
China
· Delayed Price · Currency is CNY 17.64
-0.74 (-4.03%)
Mar 9, 2026, 3:00 PM CST
Zhejiang Medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 16,721 | 15,252 | 10,281 | 11,203 | 16,368 | 13,033 | Upgrade
|
| Market Cap Growth | 12.11% | 48.35% | -8.23% | -31.56% | 25.59% | 1.87% | Upgrade
|
| Enterprise Value | 14,643 | 14,305 | 9,752 | 10,751 | 15,886 | 12,611 | Upgrade
|
| Last Close Price | 17.64 | 15.48 | 10.33 | 11.09 | 15.83 | 12.43 | Upgrade
|
| PE Ratio | 13.60 | 13.14 | 23.93 | 20.76 | 15.66 | 18.17 | Upgrade
|
| Forward PE | 16.33 | 10.55 | 13.58 | 15.18 | 12.31 | 8.94 | Upgrade
|
| PS Ratio | 1.87 | 1.63 | 1.32 | 1.38 | 1.79 | 1.78 | Upgrade
|
| PB Ratio | 1.49 | 1.40 | 1.03 | 1.15 | 1.78 | 1.62 | Upgrade
|
| P/TBV Ratio | 1.60 | 1.53 | 1.16 | 1.32 | 2.04 | 1.79 | Upgrade
|
| P/FCF Ratio | 11.03 | 28.55 | - | - | 83.06 | 18.07 | Upgrade
|
| P/OCF Ratio | 8.28 | 12.47 | 16.21 | 21.52 | 14.40 | 10.37 | Upgrade
|
| EV/Sales Ratio | 1.63 | 1.53 | 1.25 | 1.33 | 1.74 | 1.72 | Upgrade
|
| EV/EBITDA Ratio | 8.05 | 7.52 | 13.81 | 9.19 | 9.09 | 9.84 | Upgrade
|
| EV/EBIT Ratio | 12.06 | 11.46 | - | 21.95 | 13.69 | 16.22 | Upgrade
|
| EV/FCF Ratio | 9.66 | 26.78 | - | - | 80.62 | 17.48 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.07 | 0.08 | 0.09 | 0.05 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 0.52 | 0.40 | 1.15 | 0.71 | 0.27 | 0.74 | Upgrade
|
| Debt / FCF Ratio | 0.63 | 1.42 | - | - | 2.42 | 1.32 | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.14 | -0.10 | -0.11 | -0.19 | -0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.23 | -0.79 | -1.39 | -0.90 | -1.00 | -0.78 | Upgrade
|
| Net Debt / FCF Ratio | -1.47 | -2.82 | 6.02 | 2.31 | -8.88 | -1.38 | Upgrade
|
| Asset Turnover | 0.65 | 0.71 | 0.62 | 0.65 | 0.79 | 0.70 | Upgrade
|
| Inventory Turnover | 2.81 | 2.70 | 2.69 | 2.81 | 3.30 | 3.03 | Upgrade
|
| Quick Ratio | 1.95 | 1.67 | 1.39 | 1.40 | 1.30 | 1.82 | Upgrade
|
| Current Ratio | 2.79 | 2.56 | 2.26 | 2.29 | 2.00 | 2.66 | Upgrade
|
| Return on Equity (ROE) | 10.34% | 9.79% | 2.81% | 3.84% | 10.28% | 8.10% | Upgrade
|
| Return on Assets (ROA) | 5.50% | 5.87% | -0.09% | 2.45% | 6.30% | 4.66% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.25% | 11.43% | -0.16% | 4.49% | 12.30% | 8.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.50% | 11.10% | -0.20% | 4.90% | 12.20% | 9.10% | Upgrade
|
| Earnings Yield | 7.44% | 7.61% | 4.18% | 4.82% | 6.39% | 5.50% | Upgrade
|
| FCF Yield | 9.07% | 3.50% | -1.58% | -4.06% | 1.20% | 5.54% | Upgrade
|
| Dividend Yield | 2.01% | 2.39% | 1.45% | 1.53% | 2.08% | 1.85% | Upgrade
|
| Payout Ratio | 30.15% | 14.67% | 44.67% | 65.07% | 24.88% | 140.26% | Upgrade
|
| Buyback Yield / Dilution | -0.96% | -0.72% | 0.91% | -0.47% | -0.26% | -0.46% | Upgrade
|
| Total Shareholder Return | 1.05% | 1.67% | 2.36% | 1.06% | 1.83% | 1.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.